Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Amol S. Nipate, Chetan K. Jadhav, Asha V. Chate, Prashant P. Dixit, Prachi Sharma & Charansingh H. Gill. (2023) Synthesis and Antimicrobial Activity of New Carbohydrazide Bearing Quinoline Scaffolds in Silico ADMET and Molecular Docking Studies. Polycyclic Aromatic Compounds 0:0, pages 1-18.
Read now
Read now
Christopher W. Fox,Chelsea L. Khaw,Alicia K. Gerke,Brian C. Lund,. (2022) Montelukast and neuropsychiatric events – a sequence symmetry analysis. Journal of Asthma 59:12, pages 2360-2366.
Read now
Read now
Malliga R. Iyer, Biswajit Kundu & Casey M. Wood. (2022) Soluble epoxide hydrolase inhibitors: an overview and patent review from the last decade. Expert Opinion on Therapeutic Patents 32:6, pages 629-647.
Read now
Read now
Hiroto Matsuse & Shigeru Kohno. (2014) Leukotriene receptor antagonists pranlukast and montelukast for treating asthma. Expert Opinion on Pharmacotherapy 15:3, pages 353-363.
Read now
Read now
Santiago Quirce, Irina Bobolea & Pilar Barranco. (2012) Emerging drugs for asthma. Expert Opinion on Emerging Drugs 17:2, pages 219-237.
Read now
Read now
Salima Amlani, Thanu Nadarajah & Richard Andrew McIvor. (2011) Montelukast for the treatment of asthma in the adult population. Expert Opinion on Pharmacotherapy 12:13, pages 2119-2128.
Read now
Read now
Articles from other publishers (35)
Christopher Nelke, Christina B. Schroeter, Frauke Stascheit, Niklas Huntemann, Marc Pawlitzki, Alice Willison, Saskia Räuber, Nico Melzer, Ute Distler, Stefan Tenzer, Kai Stühler, Andreas Roos, Andreas Meisel, Sven G. Meuth & Tobias Ruck. (2023) Eculizumab treatment alters the proteometabolome beyond the inhibition of complement. JCI Insight 8:13.
Crossref
Crossref
Atefeh Kamali Dolatabadi, Javad Mokhtari & Nasrin Talebian. (2023) Silica xerogel carrier as encapsulating Material for the in-vitro controlled release of montelukast. Inorganic Chemistry Communications 149, pages 110378.
Crossref
Crossref
Subir Jain, Sarika Verma, Santhalingam Balamurugan, K.R. BharathKumar Reddy & D.J. Christopher. (2023) Expert opinion on the role of bilastine and bilastine-montelukast combination in the management of allergic rhinitis: An Indian perspective. The Journal of Association of Chest Physicians 11:1, pages 1.
Crossref
Crossref
Min-Lan Tsai, Hsiu-Chen Lin, Chiung-Hui Yen, Jung-Tzu Ku, Shian-Ying Sung & Hsi Chang. (2022) Increased Risk of Tourette Syndrome with Leukotriene Modifier Use in Children with Allergic Diseases and Asthma: A Nationwide Population-Based Study. Children 9:11, pages 1607.
Crossref
Crossref
Milena Sokolowska, G Enrico Rovati, Zuzana Diamant, Eva Untersmayr, Jürgen Schwarze, Zuzanna Lukasik, Florentina Sava, Alba Angelina, Oscar Palomares, Cezmi A. Akdis, Liam O'Mahony, Milos Jesenak, Oliver Pfaar, María José Torres, Marek Sanak, Sven‐Erik Dahlén & Grzegorz Woszczek. (2022) Effects of non‐steroidal anti‐inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID‐19. Allergy 77:8, pages 2337-2354.
Crossref
Crossref
Sawrab Roy, Saiful Islam, Shahrul Alam, Juned Ahmed & Q M Monzur Kader Chowdhury. (2021) Successful management of a kitten with chlorpyrifos and cypermethrin toxicosis with pralidoxime and atropine. Journal of Feline Medicine and Surgery Open Reports 7:2, pages 205511692110456.
Crossref
Crossref
Ha Ryeong Lee, Hyun Jin Park, Jun Soo Park, Dong Woo Park, Myoung Jin Ho, Dong Yoon Kim, Hyo Chun Lee, Eun Jeong Kim, Woo Heon Song, Jun Sang Park, Yong Seok Choi & Myung Joo Kang. (2021) Montelukast microsuspension with hypromellose for improved stability and oral absorption. International Journal of Biological Macromolecules 183, pages 1732-1742.
Crossref
Crossref
Neelam Singh, Giriraj T. Kulkarni & Yatendra Kumar. (2021) Therapeutic Potential of Antileukotriene Drug-Camellia sinensis Extract Co-Formulation on Histamine Induced Asthma in Guinea Pigs. Current Drug Research Reviews 13:1, pages 59-72.
Crossref
Crossref
Bei Wang, Lujin Wu, Jing Chen, Lingli Dong, Chen Chen, Zheng Wen, Jiong Hu, Ingrid Fleming & Dao Wen Wang. (2021) Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets. Signal Transduction and Targeted Therapy 6:1.
Crossref
Crossref
Milena Sokolowska, G. Enrico Rovati, Zuzana Diamant, Eva Untersmayr, Jargen Schwarze, Zuzanna Lukasik, Florentina Sava, Alba Angelina, Oscar Palomares, Cezmi A. Akdis, Liam O’Mahony, Marek Sanak, Sven‐Erik Dahlen & Grzegorz Woszczek. (2021) Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I. Allergy 76:1, pages 114-130.
Crossref
Crossref
Barry A. Finegan. 2021. Preoperative Assessment. Preoperative Assessment
97
100
.
Ludwig Aigner, Frank Pietrantonio, Diana Marisa Bessa de Sousa, Johanna Michael, Daniela Schuster, Herbert Anton Reitsamer, Horst Zerbe & Michael Studnicka. (2020) The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic. Frontiers in Molecular Biosciences 7.
Crossref
Crossref
Sung Hyun Im, Hoe Taek Jung, Myoung Jin Ho, Jeong Eun Lee, Hyung Tae Kim, Dong Yoon Kim, Hyo Chun Lee, Yong Seok Choi & Myung Joo Kang. (2019) Montelukast Nanocrystals for Transdermal Delivery with Improved Chemical Stability. Pharmaceutics 12:1, pages 18.
Crossref
Crossref
Heimo Breiteneder, Zuzana Diamant, Thomas Eiwegger, Wytske J. Fokkens, Claudia Traidl‐Hoffmann, Kari Nadeau, Robyn E. O’Hehir, Liam O’Mahony, Oliver Pfaar, Maria J. Torres, De Yun Wang, Luo Zhang & Cezmi A. Akdis. (2019) Future research trends in understanding the mechanisms underlying allergic diseases for improved patient care. Allergy 74:12, pages 2293-2311.
Crossref
Crossref
Daniel Elieh Ali Komi & Leif Bjermer. (2018) Mast Cell-Mediated Orchestration of the Immune Responses in Human Allergic Asthma: Current Insights. Clinical Reviews in Allergy & Immunology 56:2, pages 234-247.
Crossref
Crossref
Franziska Roth-Walter, Ian M. Adcock, Cristina Benito-Villalvilla, Rodolfo Bianchini, Leif Bjermer, Gaetano Caramori, Luigi Cari, Kian Fan Chung, Zuzana Diamant, Ibon Eguiluz-Gracia, Edward F. Knol, Antonios G. A. Kolios, Francesca Levi-Schaffer, Giuseppe Nocentini, Oscar Palomares, Pier Giorgio Puzzovio, Frank A. Redegeld, Betty C. A. M. van Esch & Cristiana Stellato. (2019) Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper. Allergy 74:3, pages 432-448.
Crossref
Crossref
Zuzana Diamant, Wytze Aalders, Amit Parulekar, Leif Bjermer & Nicola A. Hanania. (2019) Targeting lipid mediators in asthma. Current Opinion in Pulmonary Medicine 25:1, pages 121-127.
Crossref
Crossref
M. A. Csandl, G. Conseil & S. P. C. Cole. (2016) Cysteinyl Leukotriene Receptor 1/2 Antagonists Nonselectively Modulate Organic Anion Transport by Multidrug Resistance Proteins (MRP1-4). Drug Metabolism and Disposition 44:6, pages 857-866.
Crossref
Crossref
Monika K. Heller, Sarah C.E. Chapman & Rob Horne. (2015) Beliefs about medication predict the misattribution of a common symptom as a medication side effect — Evidence from an analogue online study. Journal of Psychosomatic Research 79:6, pages 519-529.
Crossref
Crossref
Peirsman Eva. (2015) Response to the Editor: “Fractional exhaled nitric oxide-guided algorithm for children with allergic asthma”. Pediatric Pulmonology 50:9, pages 934-935.
Crossref
Crossref
Garret W. Choby & Stella Lee. (2015) Pharmacotherapy for the treatment of asthma: current treatment options and future directions. International Forum of Allergy & Rhinology 5:S1, pages S35-S40.
Crossref
Crossref
Ann Chen Wu, Lingling Li, Vicki Fung, Elyse O. Kharbanda, Emma K. Larkin, William M. Vollmer, Melissa G. Butler, Irina Miroshnik, Donna Rusinak, Robert L. Davis, Tina Hartert, Scott T. Weiss & Tracy A. Lieu. (2014) Use of Leukotriene Receptor Antagonists Are Associated with a Similar Risk of Asthma Exacerbations as Inhaled Corticosteroids. The Journal of Allergy and Clinical Immunology: In Practice 2:5, pages 607-613.
Crossref
Crossref
Eva J. Peirsman, Thierry J. Carvelli, Pierre Y. Hage, Laurence S. Hanssens, Luc Pattyn, Marc M. Raes, Kate A. Sauer, Françoise Vermeulen & Kristine N. Desager. (2014) Exhaled nitric oxide in childhood allergic asthma management: A randomised controlled trial. Pediatric Pulmonology 49:7, pages 624-631.
Crossref
Crossref
M. Fayon, V. Feret, G. Sagbo & S. Debelleix. (2014) Alternatives à la corticothérapie inhalée dans le traitement de l’asthme de l’enfant : les anti-leucotriènes. Revue Française d'Allergologie 54:3, pages 92-95.
Crossref
Crossref
L. Li, W. M. Vollmer, M. G. Butler, P. Wu, E. O. Kharbanda & A. C. Wu. (2014) A Comparison of Confounding Adjustment Methods for Assessment of Asthma Controller Medication Effectiveness. American Journal of Epidemiology 179:5, pages 648-659.
Crossref
Crossref
Seong-Ho Hong, Jung-Taek Kwon, Ji-Young Shin, Ji-Eun Kim, Arash Minai-Tehrani, Kyeong-Nam Yu, Somin Lee, Sung-Jin Park, Seung-Hee Chang, Hu-Lin Jiang, M Vibin, Kiwon Han, Kun-Ho Son, Wie-Jong Kwak, Chanhee Chae, Sung-Hye Bang & Myung-Haing Cho. (2013)
Therapeutic Effect of
Broussonetia papyrifera
and
Lonicera japonica
in Ovalbumin-induced Murine Asthma Model
. Natural Product Communications 8:11, pages 1934578X1300801.
Crossref
Crossref
A Planagumà, T Domenech, I Jover, I Ramos, S Sentellas, R Malhotra & M Miralpeix. (2013) Lack of activity of 15-epi-lipoxin A4 on FPR2/ALX and CysLT1 receptors in interleukin-8-driven human neutrophil function. Clinical and Experimental Immunology 173:2, pages 298-309.
Crossref
Crossref
Jung-Min Lee, Hyojung Park, A Long Sae Mi Noh, Ju-Hee Kang, Ling Chen, Ting Zheng, Juhyun Lee, Sun-Young Ji, Chang-Young Jang, Chan Soo Shin, Hyunil Ha, Zang Hee Lee, Hea-Young Park, Dong-Seok Lee & Mijung Yim. (2012) 5-Lipoxygenase Mediates RANKL-Induced Osteoclast Formation via the Cysteinyl Leukotriene Receptor 1. The Journal of Immunology 189:11, pages 5284-5292.
Crossref
Crossref
Chih-Hsing Hung. (2012) Role of Leukotriene Receptor Antagonists in Asthma. Pediatrics & Neonatology 53:4, pages 219-220.
Crossref
Crossref
S. KansraA. MazzeiJ. Bhatt. (2012) Safety, Efficacy, and Patient Acceptability of Montelukast in Exercise-Induced Asthma. Clinical Medicine Insights: Therapeutics 4, pages CMT.S7389.
Crossref
Crossref
Hiroto Matsuse, Hiroko Hirose, Susumu Fukahori, Tomoko Tsuchida, Shinya Tomari, Tetsuya Kawano, Chizu Fukushima & Shigeru Kohno. (2012) Regulation of Dendritic Cell Functions against Harmful Respiratory Pathogens by a Cysteinyl Leukotrienes Receptor Antagonist. Allergy & Rhinology 3:1, pages ar.2012.3.0021.
Crossref
Crossref
Ran D. Anbar. 2012. Functional Respiratory Disorders. Functional Respiratory Disorders
227
249
.
Magnus Bäck, Sven-Erik Dahlén, Jeffrey M. Drazen, Jilly F. Evans, Charles N. Serhan, Takao Shimizu, Takehiko Yokomizo & G. Enrico Rovati. (2011) International Union of Basic and Clinical Pharmacology. LXXXIV: Leukotriene Receptor Nomenclature, Distribution, and Pathophysiological Functions. Pharmacological Reviews 63:3, pages 539-584.
Crossref
Crossref
Sheharyar R. Durrani, Ravi K. Viswanathan & William W. Busse. (2011) What effect does asthma treatment have on airway remodeling? Current perspectives. Journal of Allergy and Clinical Immunology 128:3, pages 439-448.
Crossref
Crossref
Wei-Xi Zhang & Chang-Chong Li. (2011) Airway remodeling: a potential therapeutic target in asthma. World Journal of Pediatrics 7:2, pages 124-128.
Crossref
Crossref